Amendment No. 1 to Form S-1
BluHale: New Data Tracking Device for Afrezza Inhaled Insulin
Diabetics Have Inhalable Insulin Option - YouTube
Afrezza (insulin): Basics, Side Effects & Reviews
PULMONARY DELIVERY - Pulmonary Delivery of Insulin to Treat Diabetes - A Debacle
Future of Afrezza Inhaled Insulin: Interview with Michael Castagna, CCO of MannKind Corp. | Medgadget
Insulin Information
Inhaled Insulin
Insulin Flop Costs Pfizer $2.8 Billion - WSJ
MannKind raises $102M in sale-leaseback of manufacturing plant to fund operations | Fierce Pharma
Inhaled Insulin for Diabetes Mellitus | NEJM
Inhaled Insulin: My Experience Using Afrezza - Diabetes Strong
Inhaled Insulin, Afrezza. New technology that may be right for you! – Health Park Pharmacy
Inhaled Insulin Is Quick & Easy To Use, But Is It A Game-Changer? - YouTube
Afrezza Inhaled Insulin: What You Should Know
Exubera® insulin inhaler with insulin blisters and the inhaler's... | Download Scientific Diagram
Cipla's inhalable insulin fails to get approval for trials on Indian patients - The Economic Times
Afrezza Inhaled Insulin: What You Should Know
Is Inhaled Insulin A Viable Alternative For Patients With Diabetes?
Inhaled Insulin, Afrezza. New technology that may be right for you! – Health Park Pharmacy
The Advantages of Inhaled Insulin - Children with Diabetes
Inhaled insulin stymied by drive for value - MM+M - Medical Marketing and Media
Sanofi Ends Marketing Deal With Developer of Inhaled Insulin - The New York Times
Inhaled Insulin
Inhaled Insulin: My Experience Using Afrezza - Diabetes Strong
MannKind's inhaled insulin drug proves hard for diabetics to get - Los Angeles Times
Inhaled Insulin
